Guestbook Form: The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia

By using this website and any of the materials made available through it, you agree to abide by the Terms of Use of ScholarBank@NUS and any additional terms of use attached to this item. These materials can be used for academic research, learning and teaching purposes only for yourself. Under no circumstances should the materials be disseminated to another person or used for commercial purposes.
I have carefully read and fully understood the Terms of Use and agree to accept the same.
Cancel